TY - JOUR
T1 - Development and validation of a neural network for NAFLD diagnosis
AU - Sorino, Paolo
AU - Campanella, Angelo
AU - Bonfiglio, Caterina
AU - Mirizzi, Antonella
AU - Franco, Isabella
AU - Bianco, Antonella
AU - Caruso, Maria Gabriella
AU - Misciagna, Giovanni
AU - Aballay, Laura R.
AU - Buongiorno, Claudia
AU - Liuzzi, Rosalba
AU - Cisternino, Anna Maria
AU - Notarnicola, Maria
AU - Chiloiro, Marisa
AU - Fallucchi, Francesca
AU - Pascoschi, Giovanni
AU - Osella, Alberto Rubén
N1 - Funding Information:
MICOL III: This research was supported by a public Grant from the Ministry of Health, Italy (Progetto Finaliz-zato del Ministero della Salute, ICS 160.2/RF 2003, 2004/2006). NUTRIHEP: This research was supported by a public Grant from the Ministry of Health, Italy (Progetto Finalizzato delMinistero della Salute-Progetto no. 37-2004), NUTRIHEP FOLLOW-UP: This research was supported by a public Grant from the Ministry of Health, Italy (Ricerca Corrente DDG 045 del 24.01.2017) and by Apulia Region-D.G.R. n. 1159, 28/6/ 2018 and 2019.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Non-Alcoholic Fatty Liver Disease (NAFLD) affects about 20–30% of the adult population in developed countries and is an increasingly important cause of hepatocellular carcinoma. Liver ultrasound (US) is widely used as a noninvasive method to diagnose NAFLD. However, the intensive use of US is not cost-effective and increases the burden on the healthcare system. Electronic medical records facilitate large-scale epidemiological studies and, existing NAFLD scores often require clinical and anthropometric parameters that may not be captured in those databases. Our goal was to develop and validate a simple Neural Network (NN)-based web app that could be used to predict NAFLD particularly its absence. The study included 2970 subjects; training and testing of the neural network using a train–test-split approach was done on 2869 of them. From another population consisting of 2301 subjects, a further 100 subjects were randomly extracted to test the web app. A search was made to find the best parameters for the NN and then this NN was exported for incorporation into a local web app. The percentage of accuracy, area under the ROC curve, confusion matrix, Positive (PPV) and Negative Predicted Value (NPV) values, precision, recall and f1-score were verified. After that, Explainability (XAI) was analyzed to understand the diagnostic reasoning of the NN. Finally, in the local web app, the specificity and sensitivity values were checked. The NN achieved a percentage of accuracy during testing of 77.0%, with an area under the ROC curve value of 0.82. Thus, in the web app the NN evidenced to achieve good results, with a specificity of 1.00 and sensitivity of 0.73. The described approach can be used to support NAFLD diagnosis, reducing healthcare costs. The NN-based web app is easy to apply and the required parameters are easily found in healthcare databases.
AB - Non-Alcoholic Fatty Liver Disease (NAFLD) affects about 20–30% of the adult population in developed countries and is an increasingly important cause of hepatocellular carcinoma. Liver ultrasound (US) is widely used as a noninvasive method to diagnose NAFLD. However, the intensive use of US is not cost-effective and increases the burden on the healthcare system. Electronic medical records facilitate large-scale epidemiological studies and, existing NAFLD scores often require clinical and anthropometric parameters that may not be captured in those databases. Our goal was to develop and validate a simple Neural Network (NN)-based web app that could be used to predict NAFLD particularly its absence. The study included 2970 subjects; training and testing of the neural network using a train–test-split approach was done on 2869 of them. From another population consisting of 2301 subjects, a further 100 subjects were randomly extracted to test the web app. A search was made to find the best parameters for the NN and then this NN was exported for incorporation into a local web app. The percentage of accuracy, area under the ROC curve, confusion matrix, Positive (PPV) and Negative Predicted Value (NPV) values, precision, recall and f1-score were verified. After that, Explainability (XAI) was analyzed to understand the diagnostic reasoning of the NN. Finally, in the local web app, the specificity and sensitivity values were checked. The NN achieved a percentage of accuracy during testing of 77.0%, with an area under the ROC curve value of 0.82. Thus, in the web app the NN evidenced to achieve good results, with a specificity of 1.00 and sensitivity of 0.73. The described approach can be used to support NAFLD diagnosis, reducing healthcare costs. The NN-based web app is easy to apply and the required parameters are easily found in healthcare databases.
UR - http://www.scopus.com/inward/record.url?scp=85117383088&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117383088&partnerID=8YFLogxK
U2 - 10.1038/s41598-021-99400-y
DO - 10.1038/s41598-021-99400-y
M3 - Article
AN - SCOPUS:85117383088
VL - 11
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
IS - 1
M1 - 20240
ER -